CANNTAB THERAPEUTICS LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0005 EUR | -.--% |
|
-.--% | -.--% |
| 15/04 | Canntab Therapeutics Limited announced that it expects to receive CAD 0.1 million in funding | CI |
| 2023 | Canntab Therapeutics Limited Provide an Update on Product Delivery | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Alternative Medicine
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 6.01B | ||||||
| 4.11B | ||||||
| 3.28B | - | - | ||||
| 2.83B | ||||||
| 2.31B | - | - | - | - | - |
